Thrombosis
Conference Coverage
Readmission to non-index hospital following acute stroke linked to worse outcomes
ATLANTA – Study adds to the stroke literature on nationwide estimates of 30-day readmissions.
Conference Coverage
Prior TIA proves less risky than stroke in AF patients
MONTREAL – Transient ischemic attacks get lumped with stroke when tallying embolic risk in atrial fibrillation...
Conference Coverage
DAPT’s benefit after stroke or TIA clusters in first 21 days
MONTREAL – The superiority of clopidogrel plus aspirin over aspirin alone was apparent only during the first 21 days of treatment.
Conference Coverage
Be proactive with prophylaxis to tame VTE
Dr. Jeffrey Weitz offers seven steps to improve prophylaxis in the hospital.
News
Rivaroxaban gains indication for prevention of major cardiovascular events in CAD/PAD
Rivaroxaban (Xarelto) is the first direct oral anticoagulant to gain an indication for prevention of cardiovascular events.
Conference Coverage
CT for evaluating pulmonary embolism overused
SAN ANTONIO – Computed tomography may be is overused for evaluation of pulmonary embolism.
Conference Coverage
GARFIELD-AF registry: DOACs cut mortality 19%
MUNICH – Results from a worldwide registry with more than 26,000 atrial fibrillation patients showed better survival with a direct oral...
Conference Coverage
Obesity paradox extends to PE patients
SAN ANTONIO – The obese patients in the analysis had a lower mortality risk, despite receiving more thrombolytics.
From the Journals
No significant VTE risk for women taking noncyclic COCs
Conference Coverage
Antithrombotic strategy 1 year after stenting in AF patients leans toward oral anticoagulant alone
SAN DIEGO – A primary endpoint failed to show noninferiority of oral anticoagulants alone versus anticoagulants plus antiplatelet therapy, but a...
From the Journals
Coagulopathy outbreak underscores danger of synthetic cannabinoids
Four patients died after developing spontaneous intracranial bleeding.